Core Insights - Tianjin Zhonghe Gene Technology Co., Ltd. has recently announced additional strategic investment from Changtou Hejia Fund following the completion of its Pre-A+ round financing, indicating strong market recognition of the company's strategic execution and growth potential [1] - Established in 2022 in Tianjin, China, Zhonghe Gene is a national high-tech enterprise focused on the development and commercialization of green synthesis equipment based on biological DNA synthesis technology [1] Investment Highlights - The recent investment reflects investors' confidence in the company and their long-term outlook [1] - The company has demonstrated significant strategic execution capabilities, which have been acknowledged by the capital market [1]
中合基因Pre-A+轮获得追投，助力绿色DNA合成技术产业化驶入快车道
Cai Jing Wang·2026-01-04 06:38